Additional Information
Market: AIM
Sector: Software & Computer Services
EPIC: AVIA
Latest Price: 8.63p  (0,00%)
52-week High: 45.25p
52-week Low: 5.75p
Market Cap: 0.55M
1 year chart
1 day chart
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Avia Health Informatics
www.ahi-plc.com/index.html

 

Avia Health Informatics Plc ("Avia") was incorporated in the UK, which is also its main country of operation.

Avia, via its trading subsidiary Plain Healthcare Limited ("Plain"), develops, supports and maintains the Odyssey clinical decision support software products and systems.

The Odyssey software product range is for use by clinicians and non-clinicians in healthcare and non-healthcare markets in the UK and internationally.

 

Pdf

Avia Health slashes size of potential cash call - Update

30th Jan 2012, 12:40 pm by Philip Whiterow Avia Health slashes size of potential cash call - Update

 

Healthcare support software specialist Avia Health Informatics (LON:AVIA) said today it would seek to raise a net £500,000 in new cash, a much smaller sum than the £1.5 million previously forecast.

The group added it wanted the money for new product development with a portion to be used as a working capital buffer in the event trading turned down again.

Avia added that it did not need new funds “for the sole purpose of securing the business” after recent cost-cutting and sales deals.

Cash at end December was £0.22 million, though Avia cautioned that cash headroom levels will remain tight going forward in 2012.

The firm added it is also looking for partners to fund specific products, services and/or market projects.

Avia said: “The company has taken steps to reduce its outgoings and to maintain its sales, marketing and development activity within the company's current cashflow.“ 

“This, together with the encouraging levels of interest in and new orders for PathFinderRF and the levels of renewals in the Odyssey range, have led the Board to seek a lower target fundraising compared to that thought last year,” it added.

Avia today announced a new contract for Pathfinder, its online referral communication system, from NHS Peterborough, which commissions healthcare in Cambridgeshire and Northamptonshire.

Today's deal follows one announced on 10 January - for the sale of PathFinderRF to the Lincolnshire South West Clinical Commissioning Group.

Avia today also published restated accounts for the year to March, showing revenues of £2.1 million and an operating loss of £540,000.

Shares in the group were suspended last August following concerns about the company’s financial position.

Since then, Avia said it had reduced costs by £350,000 and will cut a further £100,000 in the financial year starting in March.

Salary deferment of £200,000 in 2011 has now reduced to less that £75,000 and is forecast to reduce to zero by March 2012, Avia added.

 

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.